Grant

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

CountryUnited States
Deadline2028-06-16 (572 days left)
Published2026-08-31
SectorsHealth & life sciences, Research & innovation
SourceGrants.gov (US)

Summary

Funding opportunity PAR-27-053. CFDA: 93.279

The buyer, the value, the full description and the link to the official notice are available with a free account.